S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea · Delayed Price · Currency is KRW 21,600
+750 (3.60%)
At close: Oct 1, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 267.52 billion as of October 1, 2026. Its market cap has decreased by -12.23% in one year.
Market Cap
267.52B
Enterprise Value
247.77B
Revenue
16.49B
Ranking
n/a
PE Ratio
n/a
Stock Price
21,600.00
ChartMarket Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 267.52B, an increase of 29.51%. That is a compound annual growth rate of 7.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 267.52B | -41.01% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curocell | 328.91B |
| Inventage Lab | 318.05B |
| IMBiologics | 262.16B |
| IntoCell | 256.88B |
| HansBiomed | 256.85B |
| Genome & Company | 242.93B |
| curacle co.,ltd. | 214.26B |
| Kangstem Biotech | 200.34B |